Blog
Get the latest news about liver diseases and more
Get the latest news about liver diseases and more
Alcohol worsens fatty liver, significantly increasing mortality in high-risk patients, even with moderate intake
Recent study highlights aldafermin’s ability to reverse liver cirrhosis due to fatty liver by reducing fibrosis in patients. A significant breakthrough in treatment prospects.
We analyse the latest results of the study conducted with Resmetirom for the treatment of fatty liver disease.
Statins are effective in treating cardiovascular and liver diseases, reducing risks and improving hepatic health.
A recent study in The Lancet reveals that prevalence has tripled since 2000, with a notable increase in women and over 65 years
The study reveals that aspirin, administered for 6 months, reduces hepatic fat, improves inflammation and fibrosis in patients with fatty liver.
We analyzed the association between fatty liver disease and heavy metal exposure.
Recent studies reveal a significant connection between poor sleep duration and the risk of developing fatty liver disease.
23 de August de 2018
11 de February de 2021
29 de July de 2022
It is a viral infection of the liver that causes inflammation of the liver and the death of hepatocytes.
It is a progressive chronic inflammatory disease of the liver that can lead to liver cirrhosis.
Up to 30% of patients with cryptogenic hepatitis can be caused by the seronegative hidden infection by hepatitis C virus (HIC).
Hepatitis A is an acute inflammatory disease of the liver, caused by infection with hepatitis A virus (VAH).
Hepatitis E is an acute inflammatory disease of the liver that can lead to fulminant hepatitis.
It is the second cause of liver transplantation in the USA and in the next 10 years is expected to be the first cause. It is a serious illness if it is not treated properly.